PART I: Biologic and Molecular Basis for Regenerative Medicine
PART II: Cells and Tissue Development
PART III: Biomaterials for Regenerative Medicine
PART IV: Therapeutic Applications
Section A: Cell Therapy
Section B: Tissue Therapy
PART V: Regulation and Ethics
Anthony Atala, M.D., is the Director of the Wake Forest Institute
for Regenerative Medicine, and the W.H. Boyce Professor and Chair
of the Department of Urology at Wake Forest University. Dr. Atala
is a practicing surgeon and a researcher in the area of
regenerative medicine. His current work focuses on growing new
human cells, tissues and organs.
Dr. Atala works with several journals and serves in various roles,
including Editor-in-Chief of Current Stem Cell Research and
Therapy, and Therapeutic Advances in Urology; as Associate Editor
of the Journal of Tissue Engineering and Regenerative Medicine, The
Journal of Rejuvenation Research, Nanotechnology in Engineering and
Medicine, Gene Therapy and Regulation, and Current Reviews in
Urology; as Executive Board Member or Section Editor of the journal
Tissue Engineering and International Journal of Artificial Organs,
and as Editorial Board member of the International Journal of Stem
Cells, Stem Cell Review Letters, Expert Opinion on Biological
Therapy, Biomedical Materials, Recent Patents on Regenerative
Medicine, the Journal of the American College of Surgeons, the
Journal of Urology, BMC Urology, Urology, and Current Opinion in
Urology.
Dr. Atala is a recipient of the US Congress funded Christopher
Columbus Foundation Award, bestowed on a living American who is
currently working on a discovery that will significantly affect
society, and the Gold Cystoscope Award for advances in his field.
Dr. Atala was named by Scientific American as a Medical Treatments
Leader of the Year for his contributions to the fields of cell,
tissue and organ regeneration. In 2006, he was named by Fast
Company magazine as one of 50 people who “will change how we work
and live over the next 10 years. Dr. Atala’s work was listed as
Discover Magazine`s Number 1 Top Science Story of the Year in the
field of medicine, and as Time Magazine’s top 10 medical
breakthroughs of the year in 2007. A Time Magazine poll ranked Dr.
Atala as the 56th most influential person of the year in 2007.
Esquire Magazine in 2008 named Dr. Atala one of the 75 most
influential persons of the 21st century. Fast Company Magazine
named Dr. Atala one of 100 Most Creative People in Business in
2009. Dr. Atala was featured in U.S. News & World Report as one of
“14 Medical Pioneers Who Aren’t Holding Back.
Dr. Atala has led or served several national professional and
government committees, including the National Institutes of Health
working group on Cells and Developmental Biology, and the National
Institutes of Health Bioengineering Consortium. He is currently an
NIH “Quantum Grant awardee. Dr. Atala heads a team of over 250
physicians and researchers. Ten applications of technologies
developed in Dr. Atala's laboratory have been used clinically. He
is the editor of nine books, including Minimally Invasive Urology,
Methods of Tissue Engineering, Principles of Regenerative Medicine,
and Foundations of Regenerative Medicine, and has published more
than 300 journal articles and has applied for or received over 200
national and international patents.
Robert Lanza is an American scientist and author whose research
spans the range of natural science, from biology to theoretical
physics. TIME magazine recognized him as one of the “100 Most
Influential People in the World, and Prospect magazine named him
one of the Top 50 “World Thinkers. He has hundreds of scientific
publications and over 30 books, including definitive references in
the fields of stem cells, tissue engineering, and regenerative
medicine. He’s a former Fulbright Scholar and studied with
polio-pioneer Jonas Salk and Nobel laureates Gerald Edelman (known
for his work on the biological basis of consciousness) and Rodney
Porter. He also worked closely (and co-authored papers in Science
on self-awareness and symbolic communication) with noted Harvard
psychologist BF Skinner. Dr. Lanza was part of the team that cloned
the world’s first human embryo, the first endangered species, and
published the first-ever reports of pluripotent stem cell use in
humans. Antonios G. Mikos is the Louis Calder Professor of
Bioengineering and Chemical and Biomolecular Engineering at Rice
University. He is the Director of the J.W. Cox Laboratory for
Biomedical Engineering and the Director of the Center for
Excellence in Tissue Engineering at Rice University. He received
his Dipl.Eng. (1983) from the Aristotle University of Thessaloniki,
Greece, and his Ph.D. (1988) in chemical engineering from Purdue
University. He was a postdoctoral researcher at the Massachusetts
Institute of Technology and the Harvard Medical School before
joining the Rice faculty in 1992 as an assistant professor.
Mikos is a Member of the National Academy of Engineering; a Member
of the National Academy of Medicine; a Member of the Academy of
Medicine, Engineering and Science of Texas; and a Member of the
Academy of Athens. He is a Founding Fellow of the Tissue
Engineering and Regenerative Medicine International Society, a
Fellow of the American Association for the Advancement of Science,
a Fellow of the American Institute of Chemical Engineers, a Fellow
of the American Institute for Medical and Biological Engineering, a
Fellow of the Biomedical Engineering Society, a Fellow of the
Controlled Release Society, a Fellow of the International Union of
Societies for Biomaterials Science and Engineering, and a Fellow of
the National Academy of Inventors.
Mikos is a founding editor and editor-in-chief of the journals
Tissue Engineering Part A, Tissue Engineering Part B: Reviews, and
Tissue Engineering Part C: Methods and a member of the editorial
boards of the journals Advanced Drug Delivery Reviews, Journal of
Biomaterials Science Polymer Edition, Journal of Biomedical
Materials Research (Part A and B), and Journal of Controlled
Release. He is Past-President of the Tissue Engineering and
Regenerative Medicine International Society-Americas and the
Society For Biomaterials.
![]() |
Ask a Question About this Product More... |
![]() |